A Randomized Phase III Study of Vitamins B6 and B12 to Prevent Chemotherapy-Induced Neuropathy in Cancer Patients - Contacts and Locations

A Randomized Phase III Study of Vitamins B6 and B12 to Prevent Chemotherapy-Induced Neuropathy in Cancer Patients

This study is currently recruiting participants.

Study NCT00659269. Last updated on October 1, 2008. Information provided by University of New Mexico

Please refer to this study by its ClinicalTrials.gov identifier: NCT00659269

Contacts


Contact: Valerie Parks	505-272-0898	vparks@salud.unm.edu

Locations


United States, New Mexico
	Universtiy of New Mexico - CRTC	Recruiting
	Albuquerque, New Mexico, United States, 87131
	Contact: Valerie Parks 505-272-0898 vparks@salud.unm.edu
	Principal Investigator: Claire Verschraegen, MD

Sponsors and Collaborators

University of New Mexico

Investigators


Principal Investigator:	Claire Verschraegen, MD	University of New Mexico - CRTC